He obtained his PhD from the University of Lyon in 1997. After a 3-year postdoc at the University of Cambridge (UK), he joined the Savatier team in 2000. He studies LIF/STAT3 signalling in mouse and human ES cells. In collaboration with Hongwei Chen, he reprogrammed human ES cells to ground-like state of pluripotency. He also studies the role of long non-coding RNAs in ground state pluripotency.
Year | Reference | Title | Authors |
Journal![]() |
PUB MED | ||
---|---|---|---|---|---|---|---|
2010 | 8:125 | Krüppel-like transcription factors and control of pluripotency | Bourillot PY, Savatier P | BMC Biol | |||
2019 | 18(20):2697-2712 | Regulation of Cyclin E by transcription factors of the naïve pluripotency network in mouse embryonic stem cells | Gonnot F, Langer D, Bourillot PY, Doerflinger N, Savatier P | Cell Cycle | - | ||
1998 | 28(2):129-37 | EBV genes and B cell proliferation | Manet E, Bourillot PY, Waltzer L, Sergeant A | Crit Rev Oncol Hematol | |||
2002 | 129(9):2167-80 | A changing morphogen gradient is interpreted by continuous transduction flow | Bourillot PY, Garrett N, Gurdon JB | Development | |||
2011 | 81(3):142-52 | Embryonic stem cells in non-human primates: An overview of neural differentiation potential | Wianny F, Bourillot PY, Dehay C | Differentiation | |||
2007 | 282(9):6265-73 | Regulation of Nanog expression by phosphoinositide 3-kinase-dependent signaling in murine embryonic stem cells | Storm MP, Bone HK, Beck CG, Bourillot PY, Schreiber V, Damiano T, Nelson A, Savatier P, Welham MJ | J Biol Chem | |||
1998 | 79 ( Pt 2):363-70 | Transcriptional repression by the Epstein-Barr virus EBNA3A protein tethered to DNA does not require RBP-Jkappa | Bourillot PY, Waltzer L, Sergeant A, Manet E | J Gen Virol | |||
2000 | 94(1-2):133-46 | The Xenopus eomesodermin promoter and its concentration-dependent response to activin | Ryan K, Garrett N, Bourillot P, Stennard F, Gurdon JB | Mech Dev | |||
2018 | 34(11):944-953 | Fifty shades of pluripotency | Afanassieff M, Aksoy I, Beaujean N, Bourillot PY, Savatier P | Med Sci (Paris) | - | ||
2001 | 21(12):3901-12 | Swift is a novel BRCT domain coactivator of Smad2 in transforming growth factor beta signaling | Shimizu K, Bourillot PY, Nielsen SJ, Zorn AM, Gurdon JB | Mol Cell Biol | - | ||